Frontotemporal Dementia-Associated N279K Tau Mutation Localizes at the Nuclear Compartment

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Tau is a microtubule-associated protein crucial in Alzheimer's disease and tauopathies.
• Mutations in the MAPT gene, including N279K, cause Frontotemporal dementia with parkinsonism-17 (FTDP-17).
• The N279K mutation is known to affect alternative splicing, leading to exon 10 inclusion.

Purpose of the Study:

• To investigate the subcellular localization of the N279K mutant tau protein.
• To determine if the N279K mutation affects tau's nuclear presence and cellular viability.
• To elucidate the nuclear role of tau protein in the context of tauopathies.

Main Methods:

• Biochemical assays were performed on COS-7 cells.
• Immunohistochemistry studies were conducted on COS-7 cells.
• Cell viability was assessed to evaluate the impact of the N279K mutation.

Main Results:

• The proportion of N279K mutant tau was significantly increased in the cell nucleus compared to wild-type tau.
• No significant effect on cell viability was observed despite the altered nuclear localization of mutant tau.
• These findings highlight a differential distribution of mutant tau within neuronal cells.

Conclusions:

• The N279K tau mutation leads to an increased nuclear accumulation of tau protein.
• Altered nuclear tau localization does not compromise neuronal cell viability in this model.
• These results provide novel insights into the nuclear functions of tau and its role in FTDP-17.